Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Baxter
Express Scripts
Harvard Business School

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR PRAZIQUANTEL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Praziquantel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00215267 ↗ The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda Completed Ministry of Health, Uganda N/A 2005-09-01 The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00215267 ↗ The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda Completed DBL -Institute for Health Research and Development N/A 2005-09-01 The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00231322 ↗ Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique Completed Durban University of Technology N/A 2004-03-01 To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00231322 ↗ Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique Completed Durban University of Technology South Africa N/A 2004-03-01 To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Praziquantel

Condition Name

Condition Name for Praziquantel
Intervention Trials
Schistosomiasis 14
Healthy 8
Neurocysticercosis 4
Schistosomiasis Mansoni 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Praziquantel
Intervention Trials
Schistosomiasis 25
Schistosomiasis haematobia 8
Schistosomiasis mansoni 6
Malaria 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Praziquantel

Trials by Country

Trials by Country for Praziquantel
Location Trials
Tanzania 6
Uganda 6
Germany 5
Gabon 3
Kenya 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Praziquantel
Location Trials
Maryland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Praziquantel

Clinical Trial Phase

Clinical Trial Phase for Praziquantel
Clinical Trial Phase Trials
Phase 4 4
Phase 3 11
Phase 2/Phase 3 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Praziquantel
Clinical Trial Phase Trials
Completed 36
Recruiting 6
Not yet recruiting 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Praziquantel

Sponsor Name

Sponsor Name for Praziquantel
Sponsor Trials
DBL -Institute for Health Research and Development 8
Merck KGaA, Darmstadt, Germany 6
Merck KGaA 5
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Praziquantel
Sponsor Trials
Other 83
Industry 21
NIH 7
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Express Scripts
Moodys
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.